BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7590647)

  • 1. Hepatitis B virus precore/core variation and interferon therapy.
    Fattovich G; McIntyre G; Thursz M; Colman K; Giuliano G; Alberti A; Thomas HC; Carman WF
    Hepatology; 1995 Nov; 22(5):1355-62. PubMed ID: 7590647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
    Yoo BC; Kim HJ; Do JH; Park SM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
    Cho SW; Hahm KB; Kim JH
    Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
    J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.
    Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Takagi K; Kumada H
    J Med Virol; 2003 Jul; 70(3):355-60. PubMed ID: 12766997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.
    Kurosaki M; Enomoto N; Asahina Y; Sakuma I; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    J Med Virol; 1996 Jun; 49(2):115-23. PubMed ID: 8991934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH; Lee CM; Lu SN; Changchien CS; Wang JC; Wang JH; Hung CH; Hu TH
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance.
    Lok AS; Akarca US; Greene S
    Hepatology; 1995 Jan; 21(1):19-24. PubMed ID: 7528709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment.
    Cabrerizo M; Bartolomé J; Otero M; Ruiz-Moreno M; Carreño V
    J Med Virol; 1999 Jul; 58(3):208-14. PubMed ID: 10447414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral quasi-species evolution during hepatitis Be antigen seroconversion.
    Lim SG; Cheng Y; Guindon S; Seet BL; Lee LY; Hu P; Wasser S; Peter FJ; Tan T; Goode M; Rodrigo AG
    Gastroenterology; 2007 Sep; 133(3):951-8. PubMed ID: 17854598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion.
    Chan HL; Hussain M; Lok AS
    Hepatology; 1999 Mar; 29(3):976-84. PubMed ID: 10051506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.
    Friedt M; Gerner P; Lausch E; Trübel H; Zabel B; Wirth S
    Hepatology; 1999 Apr; 29(4):1252-8. PubMed ID: 10094972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.